Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Oncology and palliative care indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Treatment complications and lymphoedema

Oncology and palliative care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Sepsis, thrombosis or cardiopulmonary toxicity

A hot rapidly swollen limb with systemic illness, sudden cyanotic arm swelling, fever during chemotherapy, acute dyspnoea, syncope or new heart failure may represent cellulitis, upper-extremity DVT, neutropenic sepsis, embolism or treatment-related cardiac or lung injury.

Action: Use ABCDE assessment, send cultures and blood tests, start time-critical antibiotics or anticoagulation when indicated, obtain urgent venous or cardiopulmonary imaging and involve acute oncology and the breast team; do not label an acute unilateral swollen arm as routine lymphoedema before excluding dangerous alternatives.

Overview

Recognise acute and late breast-treatment toxicity, diagnose arm or breast lymphoedema without missing thrombosis or recurrence and deliver early compression, movement, skin, infection, pain and survivorship management.

Lymphoedema follows loss or dysfunction of lymphatic transport. Axillary clearance confers greater risk than sentinel biopsy, while nodal radiotherapy, obesity, infection and extensive surgery add injury. Early fluid is soft and may pit or fluctuate. Persistent protein triggers adipose deposition and fibrosis, making late swelling firm and less reversible. Breast and chest-wall oedema may show peau d’orange and heaviness without a dramatic arm-volume difference.

A swollen arm after breast cancer needs diagnostic discipline. Sudden onset, cyanosis, catheter dysfunction or collaterals suggests venous thrombosis; fever and erythema suggests cellulitis; hard nodes, progressive plexus pain or rapid refractory change suggests recurrence. Duplex ultrasound is first-line for accessible venous thrombosis, while CT or MRI evaluates central obstruction and tumour. Lymphoscintigraphy or indocyanine-green mapping answers selected uncertain or surgical-planning questions but is not required for a classic clinical case.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Oncology and palliative careOriginal SBA

Hot swollen lymphoedematous arm

A patient with chronic arm lymphoedema develops rapid spreading erythema, warmth, tenderness, fever and rigors. What is the most appropriate immediate management principle?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Oncology and palliative care topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG101 breast treatment complicationsAxillary treatment, lymphoedema information, rehabilitation and treatment monitoring.
  • NHS lymphoedema treatmentCompression, exercise, skin care and decongestive therapy.
  • Lymphoedema Support Network cellulitis guidanceCellulitis treatment and recurrent-infection prevention in lymphoedema.
  • NHS lymphoedema overviewPresentation, causes, diagnosis and complications.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Treatment aims to move fluid through remaining pathways, limit refill and prevent inflammation. Compression provides an external pressure gradient, exercise activates muscle pumps, skin care reduces microbial entry and weight management lowers load. A specialist programme may begin with multilayer bandaging and manual drainage, then transition to a fitted sleeve and self-management. Axillary web syndrome and shoulder restriction require physiotherapy because reduced movement worsens both function and lymph flow.

Survivorship review is broader than lymphoedema. Surgery can cause seroma, chronic post-mastectomy pain and reconstruction complications. Radiotherapy can cause dermatitis, breast oedema, fibrosis, pneumonitis and later cardiac or plexus injury. Chemotherapy and targeted therapy can cause neutropenia, neuropathy, cardiomyopathy and pneumonitis. Endocrine treatment affects bone, joints, thrombosis, uterus and sexual health. Each new symptom needs a toxicity, recurrence and common-disease differential rather than automatic attribution to treatment.

Key points

  • Breast-treatment lymphoedema can affect arm, hand, breast, chest wall or trunk and may arise months or years after axillary surgery or nodal radiotherapy.
  • Key early symptoms are heaviness, tightness, transient swelling, jewellery or clothing change and reduced flexibility; visible enlargement may appear only after a reversible phase.
  • Diagnosis is primarily clinical with standardised circumference, volume or bioimpedance assessment. Acute or atypical swelling requires venous thrombosis, infection and recurrence exclusion first.
  • First-line long-term management combines specialist-fitted compression, progressive exercise, weight support, skin care, self-management education and treatment of shoulder or scar dysfunction.
  • Complex decongestive therapy adds multilayer bandaging and manual lymphatic drainage in selected patients; massage alone without compression and movement is not a complete treatment.
  • Diuretics do not remove interstitial protein and are not routine lymphoedema therapy; use them only for a separate fluid-overload indication.
  • Cellulitis in a lymphoedematous limb needs prompt antibiotics, often a longer course than uncomplicated skin infection, and prevention planning after recovery.
  • Necessary venepuncture, blood pressure or urgent treatment should not be withheld when no alternative exists; minimise avoidable skin trauma and use the other limb when practical.
  • Sentinel-node biopsy, early shoulder movement, weight optimisation, prompt infection treatment and surveillance reduce morbidity but cannot guarantee prevention.
  • Investigate new or rapidly progressive swelling, hard nodes or neuropathic pain for recurrence even when lymphoedema has been stable for years.
  • Review cardiac, pulmonary, bone, menopausal, neuropathic, cognitive and sexual toxicity systematically rather than treating survivorship as cancer-free only.
  • Selected refractory disease may benefit from lymphovenous bypass, vascularised node transfer or liposuction after expert imaging and optimisation, but compression often remains necessary.

Aetiology

01

Axillary lymphatic disruption

Node surgery and regional radiotherapy remove or scar lymphatic channels; risk rises with axillary clearance, nodal radiation, infection, higher body weight and combined treatment.

02

Breast and systemic treatment injury

Surgery, radiotherapy, cytotoxic, endocrine, HER2-directed, immune and bone-modifying therapies create acute and late tissue, nerve, marrow, cardiac, lung, bone and reproductive toxicity.

03

Recurrent infection and inflammation

Skin breaks and cellulitis increase capillary leak and lymphatic injury, while protein-rich stagnant fluid impairs local immune trafficking and makes future infection more likely.

04

Cancer recurrence or venous obstruction

Axillary or supraclavicular tumour, central venous thrombosis and indwelling catheters can block drainage and may cause or worsen an apparently treatment-related swollen arm.

Pathophysiology

  1. 1
    Lymph transport capacity falls

    Damaged collectors cannot return interstitial fluid and macromolecules to the circulation, so load exceeds residual lymphatic reserve during activity, inflammation or weight gain.

  2. 2
    Protein-rich oedema drives remodelling

    Persistent interstitial protein activates macrophages, fibroblasts and adipocytes, converting early soft pitting oedema into fatty enlargement, dermal thickening and fibrosis.

  3. 3
    Muscle and respiration assist flow

    Contraction, joint movement and pressure gradients normally propel lymph; pain, cording, immobility and poor shoulder range reduce this extrinsic pump.

  4. 4
    Inflammation creates a vicious cycle

    Cellulitis further damages lymphatics and raises fluid load, while chronic oedema and skin barrier failure increase susceptibility to another infection.

  5. 5
    Other treatment toxicity accumulates

    Direct tissue injury, oxidative stress, hormonal deprivation and immune activation can damage myocardium, lung, nerves, bone and reproductive organs long after treatment ends.

Clinical features and red flags

Early lymphoedema

Heaviness, tight skin, subtle pitting, hand or breast fullness and fluctuating jewellery or sleeve fit precedes fixed enlargement.

Established fibrotic disease

Persistent non-pitting enlargement, skin thickening, positive Stemmer sign, papillomatosis and reduced joint movement indicate chronic tissue remodelling.

Axillary web syndrome

A visible or palpable painful cord from axilla down the arm limits abduction after node surgery and responds to specialist movement and manual therapy.

CellulitisRed flag

Rapid warmth, erythema, tenderness, fever, malaise and worsening swelling requires prompt antibiotic treatment and sepsis assessment.

Venous or central obstructionRed flag

Sudden cyanotic swelling, neck involvement, superficial collaterals or line dysfunction is atypical for uncomplicated chronic lymphoedema.

Possible recurrence

Hard nodularity, new supraclavicular or axillary mass, progressive brachial-plexus pain or unexplained rapid swelling requires imaging and biopsy.

Red flags requiring action

  • Fever, rigors, spreading erythema, severe pain, hypotension or confusion in a lymphoedematous limb suggests cellulitis with possible sepsis.
  • Abrupt arm and neck swelling, cyanosis, venous distension, line dysfunction or pleuritic symptoms raises upper-extremity thrombosis or central venous obstruction.
  • A new hard axillary or supraclavicular mass, progressive pain, brachial-plexus signs or rapidly worsening oedema can indicate locoregional recurrence.
  • New breathlessness, dry cough or infiltrates after radiotherapy, chemotherapy, immunotherapy or antibody–drug conjugate requires differentiation of pneumonitis, infection, embolism and progression.
  • Orthopnoea, oedema, chest pain, arrhythmia or reduced exercise tolerance after anthracycline or HER2 treatment requires prompt cardiac evaluation.
  • A tense postoperative breast, falling blood pressure, severe pain or flap colour change suggests haematoma or compromised reconstruction requiring urgent surgery.

Investigations

  1. 01
    First-line standardised limb or breast measurementFirst stepFirst line
    Why
    Confirm asymmetry, establish a baseline and track response using circumference, calculated volume, perometry or bioimpedance.
    Interpretation and limitations
    Compare both sides and prior preoperative values when available; symptoms may precede a conventional volume threshold and deserve early intervention.
  2. 02
    First-line venous duplex for acute arm swellingFirst line
    Why
    Exclude axillary and upper-arm DVT when onset, pain, catheter or venous signs are atypical for chronic lymphoedema.
    Interpretation and limitations
    A negative peripheral duplex does not exclude subclavian or central obstruction; proceed to contrast CT or venography when suspicion remains high.
  3. 03
    Cross-sectional imaging for recurrence or obstruction
    Why
    Assess nodes, chest wall, brachial plexus, central veins and thoracic disease when examination suggests tumour or proximal blockage.
    Interpretation and limitations
    Biopsy a suspicious lesion before assuming recurrence and distinguish radiation fibrosis from active tumour with multidisciplinary radiology review.
  4. 04
    Reference lymphatic imaging
    Why
    Confirm uncertain lymphatic failure and map residual drainage before selected microsurgical treatment.
    Interpretation and limitations
    Lymphoscintigraphy shows transport and dermal backflow; indocyanine-green lymphography maps superficial functional channels but is not needed for every clinical diagnosis.
  5. 05
    Infection and organ assessment
    Why
    Grade cellulitis or sepsis and identify neutropenia, renal dysfunction and another cause of generalised oedema.
    Interpretation and limitations
    Send FBC, renal and liver profile, CRP, lactate and cultures according to severity; antibiotics should not wait for results in a systemically unwell patient.
  6. 06
    Treatment-specific toxicity tests
    Why
    Investigate cardiac, pulmonary, neurological, skeletal or endocrine symptoms with the correct modality.
    Interpretation and limitations
    Use echocardiography, ECG, CT chest, nerve assessment, DEXA and thyroid or reproductive tests according to exposure and symptom rather than a non-specific survivorship panel.

Differential diagnosis

01

Upper-extremity venous thrombosis

Acute painful cyanotic swelling, venous collaterals or catheter dysfunction requires duplex and central-vein imaging because anticoagulation, not compression alone, treats the cause.

02

Locoregional cancer recurrence

New nodes, hard tissue, progressive neuropathic pain, Horner syndrome or rapid asymmetric swelling requires examination, cross-sectional imaging and biopsy.

03

Cellulitis or abscess

Warmth, spreading erythema, fever and tenderness indicate infection superimposed on or mistaken for lymphoedema and need prompt antibiotics and source assessment.

04

Seroma and postoperative change

Local fluctuant swelling soon after surgery may be a seroma or haematoma, while axillary web syndrome causes painful cords and restricted abduction.

05

Cardiac, renal or medication oedema

Bilateral dependent swelling, dyspnoea and systemic signs suggest heart or organ failure; taxanes and other medicines can cause more generalised fluid retention.

Management

01New swellingExclude urgent mimics before compressionFirst stepAn arm, breast or chest wall becomes newly or rapidly swollen after breast-cancer treatment.+
  1. 1Assess onset, fever, pain, colour, venous collaterals, catheter, nodes, respiratory symptoms and cancer history and compare both limbs and central venous territories.
  2. 2Obtain urgent duplex and central imaging for suspected thrombosis, antibiotics for cellulitis and cross-sectional imaging with biopsy for possible recurrence.
  3. 3When dangerous alternatives are excluded, document baseline volume and refer early to a lymphoedema service for an individual compression and rehabilitation plan.
02Conservative treatmentCombine compression with active self-managementPrimary breast-treatment lymphoedema is clinically established and no acute contraindication remains.+
  1. 1Fit an appropriate sleeve, glove, bra or truncal garment and teach application, wear, replacement and signs of excessive pressure or skin injury.
  2. 2Prescribe progressive resistance and aerobic exercise, shoulder and scar rehabilitation, skin moisturising and weight support, building gradually rather than restricting arm use.
  3. 3Use multilayer bandaging, manual lymphatic drainage, pneumatic compression or night garments for selected needs and measure volume and function to judge benefit.
03CellulitisTreat promptly and break recurrenceThe affected region becomes acutely warm, erythematous, tender or systemically symptomatic.+
  1. 1Mark erythema, assess sepsis and neutropenia, obtain cultures when indicated and start an antibiotic active against likely streptococci and staphylococci without delay.
  2. 2Rest and elevate initially, maintain hydration and analgesia and adjust compression temporarily if painful, resuming the usual programme as acute inflammation settles.
  3. 3After recovery, treat fungal or skin entry points, review garment fit and self-care and consider prophylactic antibiotics with a specialist after recurrent well-documented episodes.
04Refractory diseaseEscalate after optimisation and imagingEscalationPersistent swelling, fibrosis or disability remains despite well-delivered conservative treatment.+
  1. 1Confirm adherence, garment fit, body-weight factors, infection, venous obstruction and recurrent cancer and complete appropriate lymphatic mapping.
  2. 2Refer to a specialist surgical lymphoedema MDT to consider lymphovenous anastomosis for suitable functional channels, node transfer or liposuction for fat-dominant enlargement.
  3. 3Explain realistic goals, donor-site and surgical risks and the likely need for continued compression, exercise and infection prevention after intervention.
05Late toxicityInvestigate exposure-specific symptomsA survivor develops cardiopulmonary, neurological, bone, menopausal, cognitive or chronic pain symptoms.+
  1. 1Link the timing and pattern to prior surgery, radiation fields and systemic agents while also considering recurrence and common non-cancer disease.
  2. 2Order the targeted reference test and involve cardiology, respiratory, neurology, pain, menopause, bone or rehabilitation expertise before stopping beneficial cancer treatment reflexively.
  3. 3Treat the confirmed toxicity, modify the causative agent when required and record a survivorship plan that prevents repeated delayed recognition.
Key medicines and prescribing safety3 treatments · regimens, roles and cautions+
Treats likely streptococcal and staphylococcal infection promptly to prevent sepsis and additional lymphatic damage.

Flucloxacillin for lymphoedema-associated cellulitis

For a stable adult with non-purulent cellulitis and no immediate penicillin allergy, a common lymphoedema regimen is flucloxacillin 500 mg orally four times daily for 14 days, adjusted to severity, culture and local guidance.

Hospitalise and use intravenous therapy for systemic toxicity, rapid progression, neutropenia or oral failure; review at 48 hours, account for allergy and hepatic risk and do not confuse recurrence with infection.

Reduces recurrent streptococcal cellulitis when skin care, fungal treatment, compression and risk-factor management have not prevented repeated episodes.

Phenoxymethylpenicillin prophylaxis

After recurrent proven cellulitis, a specialist protocol may use phenoxymethylpenicillin 250 mg orally twice daily, often 500 mg twice daily when BMI is 33 kg/m² or higher, with duration reviewed after at least 12 months.

Confirm that episodes were cellulitis, review penicillin allergy, adherence and resistance and reassess need rather than prescribing indefinitely without lymphoedema optimisation.

Reduces burning, electric or allodynic pain from intercostobrachial or scar-related nerve injury while movement and recurrence assessment continue.

Neuropathic pain treatment

Complications

01

Recurrent cellulitis

Bacterial entry through damaged skin can cause repeated febrile episodes, hospitalisation and further irreversible lymphatic injury.

02

Fibrosis and functional impairment

Progressive tissue thickening, heaviness and reduced shoulder, hand or chest-wall movement interfere with work, exercise, sleep and self-care.

03

Chronic pain and sensory disturbance

Intercostobrachial nerve injury, scar, cording, radiation fibrosis and plexus or recurrence-related neuropathy can produce persistent mixed pain.

04

Psychological and social burden

Visible asymmetry, garment use, fear of infection and recurrence and loss of work or clothing choices can undermine body image and participation.

05

Rare lymphangiosarcoma

A new bruised, purple or nodular lesion in longstanding lymphoedema can represent Stewart–Treves angiosarcoma and requires urgent biopsy.

Monitoring and follow-up

  • Measure limb or breast volume, tissue pitting or fibrosis, skin, symptoms, shoulder range, grip and patient-defined function at baseline and after treatment changes.
  • Review garment fit, wear, washing and replacement and inspect for constriction, nerve symptoms, hand swelling and skin breakdown.
  • Track cellulitis dates, severity, organisms, entry sites and antibiotic response and reassess diagnosis before starting prophylaxis.
  • Ask at every relevant review about new nodes, focal pain, neurological deficit, chest or neck swelling and systemic symptoms that could represent recurrence or thrombosis.
  • During cardiotoxic treatment or survivorship, monitor cardiac function according to exposure and investigate symptoms immediately; do not rely on a historical normal echocardiogram.
  • During endocrine treatment, monitor bone, joints, VTE or uterine symptoms, menopause and sexual health and address adherence before toxicity causes silent discontinuation.
  • Review return to work, sleep, clothing, exercise, body image and self-management confidence because volume reduction alone does not capture meaningful recovery.

Special situations

Symptoms can precede volume change

Heaviness and tightness may reflect early lymphatic overload before a conventional percentage difference, offering a window for reversible intervention.

Compression is not one garment

Sleeve, glove, bra, truncal and night systems address different distributions and must be fitted and revised as tissue changes.

Exercise is treatment, not a prohibition

Gradually progressed resistance and aerobic activity improves function and does not increase lymphoedema when introduced with monitoring.

Diuretics remove the wrong compartment

They reduce intravascular sodium and water but not protein-rich lymphatic material, so routine use can dehydrate without correcting the mechanism.

Cellulitis and lymphoedema amplify each other

Each infection raises lymphatic injury and swelling, making rapid treatment and later prevention essential to halt a worsening cycle.

Not every swollen arm is treatment damage

Acute thrombosis, central obstruction and recurrent nodal disease remain consequential alternatives even many years after surgery.

Common pitfalls

  1. 01

    Calling sudden painful arm swelling chronic lymphoedema without excluding thrombosis and central obstruction.

  2. 02

    Starting compression over untreated cellulitis, severe arterial compromise or an undiagnosed acute process without specialist assessment.

  3. 03

    Prescribing diuretics routinely for protein-rich lymphatic oedema.

  4. 04

    Telling patients never to use the treated arm for any necessary healthcare and thereby delaying urgent access or monitoring.

  5. 05

    Using manual drainage alone without compression, movement, skin and self-management support.

  6. 06

    Stopping exercise and encouraging lifelong arm avoidance after node surgery.

  7. 07

    Treating recurrent cellulitis repeatedly without addressing fungal infection, garment problems and prophylaxis eligibility.

  8. 08

    Attributing new hard nodes or plexus pain to scar without recurrence imaging and biopsy.

  9. 09

    Reviewing cancer recurrence while ignoring chronic cardiac, bone, sexual, cognitive and functional treatment toxicity.

When post-surgical neuropathic pain is confirmed, start one guideline option such as amitriptyline 10 mg orally at night and titrate gradually to benefit and tolerability within the chronic-pain plan.

Review anticholinergic effects, sedation, falls, cardiac risk and overdose toxicity and avoid escalating medication while neglecting shoulder, scar, lymphatic or recurrent-tumour causes.